Noncardiac Chest Pain (NCCP) Clinical Trial
Official title:
Role of Esophageal Mast Cell Activation in Noncardiac Chest Pain (NCCP)
Chest pain is a common clinical complaint. About 30% patients with chest pain will have a normal coronary angiogram and are described as having noncardiac chest pain (NCCP). It is estimated that 25% of the population complain of chest pain at some time in their lifetime. The pathogenesis of NCCP is unknown. Esophageal hypersensitivity as a result of inflammation is considered to be an important mechanism in the development of this pain sensation. Little is currently known about the interaction between inflammatory mediators and peripheral afferent nerve terminals in the esophagus. The mast cell is one of the most enriched pro-inflammatory cells in the gastrointestinal tract. Activation of the mucosal mast cell releases a variety of mediators into adjacent tissues. We hypothesize that mediators released by mast cells sensitize esophageal nociceptors and induce pain sensation.
1. Key Objectives: To determine the density and activation of esophageal mast cells in
non-cardiac chest pain patients. We expect to find mast cell activation, as measured by
mast cell count or degranluation, tryptase staining, and histamine release, will be
greater in NCCP patients compared to controls, and the increased mast cell activation
will correlate with the severity of NCCP. These results will expand our understanding
of the pathogenesis of esophageal originated NCCP, and allow the development of new
diagnostic and treatment options.
2. Study Population: (i) NCCP (ii) Reflux esophagitis (iii) Control subjects.
3. Summary of Procedures: (i) symptom assessment by chest pain questionnaire; (ii)
esophageal reflux evaluation by review of records of 24-hour pH monitoring; (iii)
evidence of esophagitis by endoscopy; (iv) esophageal biopsy by endoscopy; (v) mast
cell activation study in biopsy specimen by mast cell count, tryptase and Transient
receptor potential vanniloid-1 (TRPV1) staining, and histamine release assay.
4. Major Risks & Discomforts: There are no major risks & discomforts other than involved
in standard upper GI endoscopy.
;